<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1324">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 08, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04701905</url>
  </required_header>
  <id_info>
    <org_study_id>7780</org_study_id>
    <nct_id>NCT04701905</nct_id>
  </id_info>
  <brief_title>The Offer of Neurosurgery Care in the Grand Est of France During the Health Crisis Linked to Covid-19</brief_title>
  <acronym>NeurochirCOVID</acronym>
  <official_title>The Offer of Neurosurgery Care in the Grand Est of France During the Health Crisis Linked to Covid-19</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      During this exceptional health crisis, this study of the current care of a neurosurgical&#xD;
      activity, which is essential in a University Hospital Centre, will enable us to better&#xD;
      understand how we function, the response given to a population with the means at our&#xD;
      disposal, the implementation of new therapeutic strategies and their limits, ethical&#xD;
      reflection, and, how to pursue a distributive and quality medicine.&#xD;
&#xD;
      The restriction of conventional medical resources to our care activity (resuscitation,&#xD;
      personnel, operating theatre, constraints linked to the risk of contamination...) is leading&#xD;
      to a new medical organisation imposing new Covid-19 standards, the description of which seems&#xD;
      essential to us.&#xD;
&#xD;
      A knowledge of the strategies to be adopted during a disaster health situation in order to&#xD;
      continue providing care to the civilian population. How can we prevent the setting up of&#xD;
      health care systems outside the cause of the health crisis? n triage medicine, Avoiding the&#xD;
      &quot;burn-out&quot; of doctors struck by the health crisis.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 30, 2020</start_date>
  <completion_date type="Anticipated">April 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">April 30, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Retrospective analysis of the management of neurosurgical pathologies in a health crisis situation of the Covid-19 pandemic</measure>
    <time_frame>The files analysed retrospectily from March 16, 2020 to June 15, 2020 will be examined]</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">450</enrollment>
  <condition>COVID-19 Pandemic</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patient entering the neurosurgery care sector requiring treatment between 03/16/2020 and&#xD;
        06/15/2020&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient aged over 18;&#xD;
&#xD;
          -  Entering the neurosurgery care sector requiring support between 03/16/2020 and&#xD;
             06/15/2020;&#xD;
&#xD;
          -  Having not expressed his opposition, after information, to the reuse of his data for&#xD;
             the purposes of this research.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Subject having expressed opposition to participating in the study&#xD;
&#xD;
          -  Subject under guardianship or guardianship&#xD;
&#xD;
          -  Subject under safeguard of justice&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>François PROUST, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Neurosurgery - Strasbourg University Hospitals</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>François PROUST, MD, PhD</last_name>
    <phone>33 3 88 12 76 12</phone>
    <email>francois.proust@chru-strasbourg.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Saïd CHAYER, PhD, HDR</last_name>
    <phone>33 3 88 11 66 90</phone>
    <email>said.chayer@chru-strasbourg.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Neurosurgery - Strasbourg University Hospitals</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>François PROUST, MD, PhD</last_name>
      <phone>33 3 88 12 76 12</phone>
      <email>francois.proust@chru-strasbourg.fr</email>
    </contact>
    <contact_backup>
      <last_name>Saïd CHAYER, PhD, HDR</last_name>
      <phone>33 3 88 11 66 90</phone>
      <email>said.chayer@chru-strasbourg.fr</email>
    </contact_backup>
    <investigator>
      <last_name>François PROUST, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Salvatore Chibbaro, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Helene Cebula, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Irene Ollivier, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>January 7, 2021</study_first_submitted>
  <study_first_submitted_qc>January 7, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 8, 2021</study_first_posted>
  <last_update_submitted>January 7, 2021</last_update_submitted>
  <last_update_submitted_qc>January 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>COVID-19 Pandemic</keyword>
  <keyword>Coronavirus</keyword>
  <keyword>Sars-cov-2</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

